(12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) <li /> EO ...

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...

New U.S. investor The Institute for Follicular Lymphoma Innovation (IFLI), a global non-profit foundation dedicated to advancing research and treatment for follicular lymphoma, invested $9 million in ...

Pheast Therapeutics, a clinical-stage biotechnology company developing novel therapies to unleash the power of macrophages on aggressive, difficult-to-treat cancers, today announced that the U.S. Food ...

Immune escape plays an important role in tumor recurrence, metastasis, and drug resistance. Tumors evade immune response through various mechanisms, among which cancer immunoediting is widely accepted ...

Immune escape is a key mechanism of cancer progression and metastatic dissemination and creates a serious obstacle to successful cancer treatment. It has been widely recognized, indeed, that cancerous ...

Our immune system is constantly monitoring our body. In order to survive, cancer cells need to evade this surveillance. Now a new study by researchers at the Netherlands Cancer Institute reveals a ...

1998; Rebouissou et al., 2016). This group of tumors has an important unifying feature: they cannot be infiltrated by cells of the immune system, and are therefore resistant to immunotherapy. But it ...